Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Randomised controlled trial of a specialist behaviour therapy team versus treatment as usual
ISRCTN ISRCTN62134865
ClinicalTrials.gov identifier
Public title Randomised controlled trial of a specialist behaviour therapy team versus treatment as usual
Scientific title
Acronym REBILD
Serial number at source NRR: N0628169668
Study hypothesis 1. Specialist behaviour therapy services for challenging behaviour (CB) do not significantly reduce such behaviour in adults with learning disability as measured by the Aberrant Behaviour Checklist (ABC)
2. There is no difference in cost effectiveness between the two models
Lay summary
Ethics approval West Essex Local Research Ethics Committee, approval date: 08/04/2005, reference number: 05/Q0301/9
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Challenging behaviour
Participants - inclusion criteria 1. People over 16 years of age
2. All levels of learning disability (LD)
Participants - exclusion criteria 1. Mental illness or substance use if the main reason for CB
2. Medical illness if the main cause of CB
Anticipated start date 01/04/2005
Anticipated end date 31/03/2008
Status of trial Completed
Patient information material
Target number of participants 60
Interventions Specialist behaviour team administering behaviour therapy versus treatment as usual
Primary outcome measure(s) Reduction in CB as measured by the ABC over the follow-up period
Secondary outcome measure(s) 1. Improvement in mental state
2. Increase in quality of life scores
3. Reduction in carer burden and cost effectiveness as shown by reduction in care costs
Sources of funding South Essex Partnership NHS Trust (UK) (Grant reference number: GRG3)
Trial website
Publications 2009 results in http://www.ncbi.nlm.nih.gov/pubmed/19687128
Contact name Dr  Angela  Hassiotis
  Address Department of Mental Health Sciences
48 Riding House Street
  City/town London
  Zip/Postcode W1W 7EY
  Country United Kingdom
  Email a.hassiotis@ucl.ac.uk
Sponsor South Essex Partnership NHS Trust (UK)
  Address Trust Head Office
Dunton Court
Aston Road
  City/town Laindon
  Zip/Postcode SS15 6NX
  Country United Kingdom
  Tel +44 (0)1375 364650
  Email chief.executive@southessex-trust.nhs.uk
Date applied 08/03/2006
Last edited 16/11/2009
Date ISRCTN assigned 25/05/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central